1. Home
  2. SFST vs ALDX Comparison

SFST vs ALDX Comparison

Compare SFST & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SFST
  • ALDX
  • Stock Information
  • Founded
  • SFST 1999
  • ALDX 2004
  • Country
  • SFST United States
  • ALDX United States
  • Employees
  • SFST N/A
  • ALDX N/A
  • Industry
  • SFST Major Banks
  • ALDX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SFST Finance
  • ALDX Health Care
  • Exchange
  • SFST Nasdaq
  • ALDX Nasdaq
  • Market Cap
  • SFST 344.3M
  • ALDX 319.4M
  • IPO Year
  • SFST 1999
  • ALDX 2014
  • Fundamental
  • Price
  • SFST $40.51
  • ALDX $4.86
  • Analyst Decision
  • SFST Buy
  • ALDX Strong Buy
  • Analyst Count
  • SFST 1
  • ALDX 2
  • Target Price
  • SFST $44.00
  • ALDX $10.00
  • AVG Volume (30 Days)
  • SFST 16.2K
  • ALDX 430.5K
  • Earning Date
  • SFST 01-16-2025
  • ALDX 11-07-2024
  • Dividend Yield
  • SFST N/A
  • ALDX N/A
  • EPS Growth
  • SFST N/A
  • ALDX N/A
  • EPS
  • SFST 1.73
  • ALDX N/A
  • Revenue
  • SFST $90,166,000.00
  • ALDX N/A
  • Revenue This Year
  • SFST N/A
  • ALDX N/A
  • Revenue Next Year
  • SFST $13.55
  • ALDX N/A
  • P/E Ratio
  • SFST $24.80
  • ALDX N/A
  • Revenue Growth
  • SFST 3.18
  • ALDX N/A
  • 52 Week Low
  • SFST $24.98
  • ALDX $2.71
  • 52 Week High
  • SFST $45.91
  • ALDX $6.55
  • Technical
  • Relative Strength Index (RSI)
  • SFST 50.19
  • ALDX 56.01
  • Support Level
  • SFST $41.82
  • ALDX $4.82
  • Resistance Level
  • SFST $42.90
  • ALDX $5.42
  • Average True Range (ATR)
  • SFST 0.87
  • ALDX 0.29
  • MACD
  • SFST -0.39
  • ALDX 0.05
  • Stochastic Oscillator
  • SFST 21.24
  • ALDX 80.52

About SFST Southern First Bancshares Inc.

Southern First Bancshares Inc is a bank holding company. The company engaged in the business of accepting demand deposits and savings deposits insured by the Federal Deposit Insurance Corporation (the "FDIC"), and providing commercial, consumer and mortgage loans to the general public of which a majority of the revenue is derived from the Commercial and Retail Banking segment which includes the provision of traditional deposit and lending products and services to its commercial and retail banking clients.

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.

Share on Social Networks: